Showing results (121-130 of 231) with videos related to

Sort By:
Pageof 24
The Journal of Clinical Endocrinology and Metabolism|December 3, 2019
Histological Characterization of Aldosterone-producing Adrenocortical Adenomas with Different Somatic MutationsYoshikiyo Ono, Yuto Yamazaki, Kei Omata, et al.
Human Pathology|March 10, 2019
TP53 missense mutation is associated with increased tumor-infiltrating T cells in primary prostate cancerHarsimar B Kaur, Jiayun Lu, Liana B Guedes, et al.
Urologic Oncology|November 10, 2021
Association of MyProstateScore (MPS) with prostate cancer grade in the radical prostatectomy specimenNicholas W Eyrich, John T Wei, Yashar S Niknafs, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 1, 2018
Association of tumor-infiltrating T-cell density with molecular subtype, racial ancestry and clinical outcomes in prostate cancerHarsimar B Kaur, Liana B Guedes, Jiayun Lu, et al.
European Urology|August 2, 2016
Prevalence and Prognostic Significance of PTEN Loss in African-American and European-American Men Undergoing Radical ProstatectomyJeffrey J Tosoian, Fawaz Almutairi, Carlos L Morais, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 10, 2019
Tubulocystic renal cell carcinoma: a distinct clinicopathologic entity with a characteristic genomic profileJudy Sarungbam, Rohit Mehra, Scott A Tomlins, et al.
EMBO Molecular Medicine|March 20, 2015
Consequence of the tumor-associated conversion to cyclin D1bMichael A Augello, Lisa D Berman-Booty, Richard Carr, et al.
The Journal of Molecular Diagnostics : JMD|August 28, 2021
Development and Validation of StrataNGS, a Multiplex PCR, Semiconductor Sequencing-Based Comprehensive Genomic Profiling TestScott A Tomlins, Daniel H Hovelson, Paul Harms, et al.
JCO Precision Oncology|August 25, 2020
Circulating Tumor Cells as a Predictor of Treatment Response in Clinically Localized Prostate CancerSimpa S Salami, Udit Singhal, Daniel E Spratt, et al.
Cancer Cell|November 13, 2007
Integrative genomics analysis reveals silencing of beta-adrenergic signaling by polycomb in prostate cancerJindan Yu, Qi Cao, Rohit Mehra, et al.
Pageof 24